Stockholm - Delayed Quote SEK
LIDDS AB (publ) (LIDDS.ST)
At close: October 18 at 5:29 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
--
--
1,888.0000
3,554.0000
345.0000
--
Operating Expense
26,129.0000
40,674.0000
38,506.0000
40,824.0000
32,670.0000
--
Operating Income
-26,112.0000
-40,674.0000
-36,618.0000
-37,270.0000
-32,325.0000
--
Net Non Operating Interest Income Expense
512.0000
468.0000
-243.0000
--
-8.0000
--
Pretax Income
-25,600.0000
-40,206.0000
-36,860.0000
-37,270.0000
-32,334.0000
--
Net Income Common Stockholders
-25,600.0000
-40,206.0000
-36,860.0000
-37,270.0000
-32,334.0000
--
Diluted NI Available to Com Stockholders
-25,600.0000
-40,206.0000
-36,860.0000
-37,270.0000
-32,334.0000
--
Basic EPS
-0.37
-0.63
-1.07
-1.08
-1.12
--
Diluted EPS
-0.37
-0.63
-1.07
-1.08
-1.12
--
Basic Average Shares
86,630.8560
63,456.0000
34,396.0000
34,441.9530
28,913.2110
--
Diluted Average Shares
136,463.3260
63,456.0000
34,396.0000
34,441.9530
28,913.2110
--
Total Operating Income as Reported
-26,112.0000
-40,674.0000
-36,617.0000
-37,269.0000
-32,326.0000
--
Rent Expense Supplemental
--
--
--
--
708.0000
625.0000
Total Expenses
26,112.0000
40,674.0000
38,506.0000
40,824.0000
32,670.0000
--
Net Income from Continuing & Discontinued Operation
-25,600.0000
-40,206.0000
-36,860.0000
-37,270.0000
-32,334.0000
--
Normalized Income
-25,600.0000
-40,206.0000
-36,860.0000
-37,270.0000
-32,334.0000
--
Interest Income
--
529.0000
19.0000
--
--
--
Interest Expense
16.0000
61.0000
262.0000
--
8.0000
--
Net Interest Income
512.0000
468.0000
-243.0000
--
-8.0000
--
EBIT
-25,584.0000
-40,145.0000
-36,598.0000
-37,270.0000
-32,326.0000
--
EBITDA
-9,537.0000
-24,457.0000
-36,114.0000
-36,806.0000
-31,838.0000
--
Reconciled Depreciation
-64.0000
475.0000
484.0000
464.0000
488.0000
--
Net Income from Continuing Operation Net Minority Interest
-25,600.0000
-40,206.0000
-36,860.0000
-37,270.0000
-32,334.0000
--
Normalized EBITDA
-9,537.0000
-24,457.0000
-36,114.0000
-36,806.0000
-31,838.0000
--
12/31/2019 - 7/31/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MODTX.ST Modus Therapeutics Holding AB (publ)
1.3800
-4.17%
APTA.ST Aptahem AB (publ)
1.6400
-0.61%
NANECH.ST NanoEcho AB
0.2645
+8.62%
QUIA.ST Quia Pharma AB (publ)
0.0200
-6.10%
LPGO.ST Lipigon Pharmaceuticals AB (publ)
0.1840
-0.54%
ZICC.ST Ziccum AB (publ)
2.3000
0.00%
CYXO.ST Cyxone AB (publ)
0.0400
-2.44%
ABLI.ST Abliva AB (publ)
0.1550
+1.04%
ALZ.ST Alzinova AB (publ)
3.6600
+3.39%
ATORX.ST Alligator Bioscience AB (publ)
1.2620
0.00%